IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome
about
sameAs
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsCurrent status of biomarker research in neurologyBiomarkers in Multiple Sclerosis: An Up-to-Date OverviewBiomarkers of treatment response in multiple sclerosisGenomic regions associated with multiple sclerosis are active in B cellsMeasles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis[Clinically isolated syndrome].Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein.A proteomic approach for the diagnosis of bacterial meningitisThe chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years.Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureCerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.Vitamin D receptor binding, chromatin states and association with multiple sclerosis.Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.The MRZ reaction in primary progressive multiple sclerosisThe effect of gender in clinically isolated syndrome (CIS): a meta-analysis.The evidence for a role of B cells in multiple sclerosis.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients.Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis.Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis.Oligoclonal bands predict multiple sclerosis in children with optic neuritis.Multiple sclerosis: Oligoclonal bands--a useful tool to avoid MS misdiagnosis.
P2860
Q21093230-C829D8BC-2B75-40B3-887D-D45CD5505ABEQ26744505-3EAA8A2B-35B6-4B7D-9596-F6EDD1158838Q27496017-102AF183-529C-4A09-8975-5D5A3B7D1F3BQ28305094-45D328AD-997A-4ADF-8A23-DD4DDBD06382Q28731577-7B1C713A-806B-4446-A19A-7E036997DE24Q28732705-539B6D92-DAD7-4CB6-A52D-8016484C6988Q30670868-0F90ECD8-4296-4F94-83F9-2A5A3291AF69Q30712257-D40659CB-58CE-4B43-8E8C-8D5BFA69E39BQ33527947-B4C686B6-D74E-48C9-890B-D7826ADD3829Q33553299-EB6AE80F-DF87-415C-BC25-6EF72E4F7D16Q33654152-D1BE0C7A-DF1E-43B4-B188-5EA1EFD35994Q33911364-C64E3DB6-E98A-4C90-AC48-4BEFDE25717FQ35004738-C40501FC-0B83-4B0D-8D5F-57FBBFEA26A3Q35078327-0B3294CB-CBAB-4508-B005-7DC84993E94BQ35138419-9596BF3B-66F8-4640-A027-65995A537B08Q35864847-02D56954-303D-4C62-B6C3-04E0442ECAA2Q36122415-63EB0E47-C8A2-43D7-A881-6E8FD4539102Q37416267-8712818E-7B2D-4862-996A-DA6B5E46C5F4Q37628035-48780031-2675-420C-9737-2A10D1002BFEQ37945048-F782EBEE-4F95-436B-967E-83FA35E7649BQ37993033-E079FBDE-D0C4-40A7-9795-174B3E60B9C9Q38088747-AC0A4108-16DB-4882-9854-25324B2C76ABQ38092972-2A4BA560-7127-4322-A635-7DC4BD17AE5EQ38121632-C0C6B520-F763-4021-A850-34E37D760E3BQ38198016-D7A1A012-3CF3-4728-A58C-6F35D4F31612Q38590773-60F6FF46-6527-4F80-B16F-F114BA5CA2BCQ38654791-57F59DB2-036C-44AE-A4BE-4D180FFD5E74Q38679190-00B69976-5DD7-4230-A94B-6FD15F413CF6Q39027028-E3D03E21-4AFA-4F1D-B38B-9782F96DD2CEQ39251519-E6368998-78A0-4C6B-A893-B0FDCDA9B47BQ40046059-3E83815C-B39B-4E96-B3D1-8A2D642C363BQ40402131-34167B0E-84CD-41C2-8F66-53605EA6DC9CQ40505202-DA854071-29A6-4FC2-878A-0CA1A1697DABQ41349564-6E3778EC-C457-4465-84B5-923BCE278A37Q42181305-23951349-BBB2-4D8B-90B0-A074B134EAA6Q43430323-A59C98A7-D23E-4026-9CD0-75E3841906E0Q45325350-023CAEC1-1B19-4967-B0AF-B3BD2AA9A5C0Q47105069-F27F9D7A-7833-4AE4-B881-0C97E6E6908BQ50594301-E7D8A6CD-FFE6-410F-AD60-E0E8136196F6Q51067103-D15D3989-4513-4A73-8FB0-BE7C00CD180B
P2860
IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IgG antibodies against measles ...... n clinically isolated syndrome
@ast
IgG antibodies against measles ...... n clinically isolated syndrome
@en
IgG antibodies against measles ...... n clinically isolated syndrome
@nl
type
label
IgG antibodies against measles ...... n clinically isolated syndrome
@ast
IgG antibodies against measles ...... n clinically isolated syndrome
@en
IgG antibodies against measles ...... n clinically isolated syndrome
@nl
prefLabel
IgG antibodies against measles ...... n clinically isolated syndrome
@ast
IgG antibodies against measles ...... n clinically isolated syndrome
@en
IgG antibodies against measles ...... n clinically isolated syndrome
@nl
P2093
P2860
P921
P3181
P1433
P1476
IgG antibodies against measles ...... n clinically isolated syndrome
@en
P2093
Gayle Richards
Hayrettin Tumani
Johannes Brettschneider
Markus Otto
Rainer Muche
Ulrike Kiechle
Vera Lehmensiek
P2860
P3181
P356
10.1371/JOURNAL.PONE.0007638
P407
P577
2009-11-05T00:00:00Z